These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26687932)

  • 1. KCNQ potassium channels in sensory system and neural circuits.
    Wang JJ; Li Y
    Acta Pharmacol Sin; 2016 Jan; 37(1):25-33. PubMed ID: 26687932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kv7 (KCNQ) channel modulators and neuropathic pain.
    Munro G; Dalby-Brown W
    J Med Chem; 2007 May; 50(11):2576-82. PubMed ID: 17489574
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonreciprocal mechanisms in up- and downregulation of spinal motoneuron excitability by modulators of KCNQ/Kv7 channels.
    Lombardo J; Harrington MA
    J Neurophysiol; 2016 Nov; 116(5):2114-2124. PubMed ID: 27512022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways modulating neural KCNQ/M (Kv7) potassium channels.
    Delmas P; Brown DA
    Nat Rev Neurosci; 2005 Nov; 6(11):850-62. PubMed ID: 16261179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kv7 Channels and Excitability Disorders.
    Jones F; Gamper N; Gao H
    Handb Exp Pharmacol; 2021; 267():185-230. PubMed ID: 33860384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KCNQ channels in nociceptive cold-sensing trigeminal ganglion neurons as therapeutic targets for treating orofacial cold hyperalgesia.
    Abd-Elsayed AA; Ikeda R; Jia Z; Ling J; Zuo X; Li M; Gu JG
    Mol Pain; 2015 Jul; 11():45. PubMed ID: 26227020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation as a new regulatory mechanism for neuronal Kv7 channels.
    Jensen HS; Grunnet M; Olesen SP
    Biophys J; 2007 Apr; 92(8):2747-56. PubMed ID: 17237198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KV7 channelopathies.
    Maljevic S; Wuttke TV; Seebohm G; Lerche H
    Pflugers Arch; 2010 Jul; 460(2):277-88. PubMed ID: 20401729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kv1.1 channels act as mechanical brake in the senses of touch and pain.
    Hao J; Padilla F; Dandonneau M; Lavebratt C; Lesage F; Noël J; Delmas P
    Neuron; 2013 Mar; 77(5):899-914. PubMed ID: 23473320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds.
    Xiong Q; Gao Z; Wang W; Li M
    Trends Pharmacol Sci; 2008 Feb; 29(2):99-107. PubMed ID: 18206251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased susceptibility to acetylcholine in the entorhinal cortex of pilocarpine-treated rats involves alterations in KCNQ channels.
    Maslarova A; Salar S; Lapilover E; Friedman A; Veh RW; Heinemann U
    Neurobiol Dis; 2013 Aug; 56():14-24. PubMed ID: 23583611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal KCNQ potassium channels: physiology and role in disease.
    Jentsch TJ
    Nat Rev Neurosci; 2000 Oct; 1(1):21-30. PubMed ID: 11252765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of KCNQ/M (Kv7) potassium channels in the spinal cord contributes to the sensitization of dorsal horn WDR neurons and pain hypersensitivity in a rat model of bone cancer pain.
    Cai J; Fang D; Liu XD; Li S; Ren J; Xing GG
    Oncol Rep; 2015 Mar; 33(3):1540-50. PubMed ID: 25592230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C shifts the voltage dependence of KCNQ/M channels expressed in Xenopus oocytes.
    Nakajo K; Kubo Y
    J Physiol; 2005 Nov; 569(Pt 1):59-74. PubMed ID: 16179364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kv7 channels as targets for the treatment of pain.
    Wickenden AD; McNaughton-Smith G
    Curr Pharm Des; 2009; 15(15):1773-98. PubMed ID: 19442190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Kv7 channels and excitability in the brain.
    Greene DL; Hoshi N
    Cell Mol Life Sci; 2017 Feb; 74(3):495-508. PubMed ID: 27645822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KCNQ2/3 openers show differential selectivity and site of action across multiple KCNQ channels.
    Zhang D; Thimmapaya R; Zhang XF; Anderson DJ; Baranowski JL; Scanio M; Perez-Medrano A; Peddi S; Wang Z; Patel JR; DeGoey DA; Gopalakrishnan M; Honore P; Yao BB; Surowy CS
    J Neurosci Methods; 2011 Aug; 200(1):54-62. PubMed ID: 21723881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KCNQ-Encoded Potassium Channels as Therapeutic Targets.
    Barrese V; Stott JB; Greenwood IA
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():625-648. PubMed ID: 28992433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic potential of neuronal K V 7 (KCNQ) channel modulators: an update.
    Gribkoff VK
    Expert Opin Ther Targets; 2008 May; 12(5):565-81. PubMed ID: 18410240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M-channels: neurological diseases, neuromodulation, and drug development.
    Cooper EC; Jan LY
    Arch Neurol; 2003 Apr; 60(4):496-500. PubMed ID: 12707061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.